# Curavit Clinical Research

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/curavit-clinical-research

- Industry: Software
- Headquarters: Scarsdale, US
- Website: www.curavitclinicalresearch.com
- Total disclosed funding: $8.5M
- Latest round: Series A (Sep 28, 2022)
- Investors on record: 3

## About

Founded in 2019 and based in New York, US, Curavit Clinical Research Corp operates as a provider of virtual clinical research organizations for planning and carrying out decentralized medical studies. From 2019 to 2023, the company has collaborated with some other digital therapeutics companies, including Swing Therapeutics, Lark Health, Curio, and Sana to conduct researches. It also partnered with life sciences digital technology and data providers, including Ripple Science, for its direct-to-patient software platform; ixlayer, to provide easy access to clinical-grade diagnostic lab testing in DCTs; and 1nHealth, for digital patient recruitment and enrollment. And the company joined the Digital Therapeutics Alliance, a 501(c)(6) non-profit trade association. In October 2022, Curavit Clinical Research Corp raised USD 8.5 million in series A funding led by new investor Osage Venture Partners, with participation from other new investors Narrow Gauge Venture Syndicate and Royal Street Ventures. Individual investors also participated in the round.

The company focuses its business at decentralized clinical trials (DCTs) field. The company's main product is a platform called Stratus, which digitalize the traditional clinical trials by enabling solicit, screen, enroll, remote monitoring, reporting, analyzing and regulatory affair support. The use cases for this platform include DTx Applications, Labs and EHR Inputs, and Standard Clinical Trials.

The company will use the fund raised in 2022 to further develop its platform and business recognition of its digital service offerings.

## Funding rounds

- Series A, Sep 28, 2022, $8.5M — Royal Street Ventures, Osage Venture Partners, Narrow Gauge Venture Syndicate

## Investors

- Royal Street Ventures (https://capitalatlas.ai/funds/royal-street-ventures) — Series A
- Osage Venture Partners (https://capitalatlas.ai/funds/osage-venture-partners) — Series A
- Narrow Gauge Venture Syndicate (https://capitalatlas.ai/funds/narrow-gauge-venture-syndicate) — Series A